About ORTHOCON
ORTHOCON is a company based in Irvington (United States) founded in 2005 was acquired by Abyrx in April 2013. ORTHOCON has raised $27.16 million across 2 funding rounds from investors including Canaan, Abyrx and BB Biotech Ventures. ORTHOCON offers products and services including Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty. ORTHOCON operates in a competitive market with competitors including Stryker, Zimmer Biomet, Humacyte, Smith & Nephew and NuVasive, among others.
- Headquarter Irvington, United States
- SectorsHealthcare
- Website orthocon.com
- Social LinkedIn
- Acquired by Abyrx (Apr 2013)
- Legal Name Abyrx, Inc.
Products & Services of ORTHOCON
ORTHOCON offers a comprehensive portfolio of products and services, including Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty.
Provides hemostasis for bone surfaces during surgical procedures.
Settable putty that adheres to bleeding bone in surgical applications.
Hemostatic solution for easy application in bone surgery.
Funding Insights of ORTHOCON
ORTHOCON has successfully raised a total of $27.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $2.16 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27.16M
- Total Rounds 2
- Last Round Series B — $2.16M
- First Round $25M
(Apr 2009)
- Investors Count 3
All 2 funding rounds of ORTHOCON with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2010 | $2.16M | Series B | – | – | |
| Apr 2009 | $25M | Series B | – | Canaan, ProQuest Investments |
4 investors in total: 4 institutional.
Investors in ORTHOCON
ORTHOCON has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Canaan, Abyrx and BB Biotech Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Canaan is recognized as an early-stage venture capital firm. | 1987 | canaan.com | San Francisco, United States | |
- | – | bbbiotechventures.com | - | |
- | – | proquestvc.com | - | |
Hemostatic bone putty is developed for surgical bone bleeding control. | 2013 | abyrx.com | Irvington, United States |
Investor details for ORTHOCON
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ORTHOCON
4 dated milestones of ORTHOCON across 8 years, from founding to its latest funding, stage changes and deals.
- Founded ORTHOCON is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Series B, of $2.2M.
- Exit Acquired by Abyrx.
Competitors of ORTHOCON
ORTHOCON operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Zimmer Biomet, Humacyte, Smith & Nephew and NuVasive, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| stryker.com | 1941 | Kalamazoo, United States | – | 25,035 | 3D-printed orthopedic products are manufactured for medical applications. | |
| zimmerbiomet.com | 1927 | Warsaw, United States | $1.73M | 18,000 | Medical devices for multiple health purposes are manufactured. | |
| humacyte.com | 2004 | Morrisville, United States | $424.76M | 70 | Human tissue-based products are developed for vascular disease applications. | |
| smith-nephew.com | 1856 | London, United Kingdom | – | 18,976 | Manufacturer of knee, hip and shoulder joint replacements | |
| nuvasive.com | 1997 | San Diego, United States | $54.1M | 2,450 | Smart surgical devices for spinal surgery are developed. | |
| carlsmed.com | 2018 | San Diego, United States | $109.63M | 59 | Developer of devices for spine surgery | |
| intech-medical.com | 2000 | – | – | 271 | Surgical instruments for orthopaedics are developed and manufactured. | |
| zavation.com | 2010 | Flowood, United States | – | 110 | Medical devices for spine surgery are designed, manufactured, and distributed. | |
| cutiss.swiss | 2017 | Zurich, Switzerland | $94.37M | – | Personalized skin tissue therapy is developed by CUTISS for surgeries. | |
| arthrex.com | 1981 | Naples, United States | – | 2,244 | Orthopedic devices and arthroscopy education are developed by Arthrex. |
Detailed competitors of ORTHOCON
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orthocon
Complete news archive for ORTHOCON
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ORTHOCON
10 companies that operate in the same segment as ORTHOCON (Orthopedics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Prosthetic and orthotic devices are developed for individuals with disabilities. | 1919 | Duderstadt, Lower Saxony, Germany | USD 17 M | USD 1.97 B | – | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of drugs for treating rare and autoimmune diseases | 2008 | Dublin, Ireland | USD 61.78 M | USD 617.41 M | – | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Robotic arms are provided for mobility and rehabilitation support. | 2004 | Boston, Massachusetts, United States | USD 17.21 M | USD 40.93 M | 185 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Exoskeletons for medical rehabilitation and industrial productivity are provided. | 2005 | United States | USD 24.37 M | USD 71.6 M | 61 | |
Stabilization devices for healthcare are manufactured by the company. | 2005 | New York, New York, United States | USD 142.15 M | – | 43 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ORTHOCON
ORTHOCON was founded in 2005 and raised its 1st funding round 4 years after it was founded.
ORTHOCON is headquartered in Irvington, United States. It is registered at Irvington, New Jersey, United States.
ORTHOCON is a funded company, having raised a total of $27.16M across 2 funding rounds to date. The company's 1st funding round was a Series B of $25M, raised on Apr 2009.
Orthocon was founded in 2005 and is based in Irvington, United States. Operations focus on medical therapeutics within the orthopaedic and spine surgery sectors. Resorbable products, including the FDA-approved HEMASORB Bone Hemostat Matrix, are created to address active bone bleeding. This synthetic matrix is applied directly to sites and is substantially resorbed within 30 days, supporting surgical procedures.
ORTHOCON offers Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty.
ORTHOCON operates through Abyrx, Inc..
Yes. ORTHOCON was acquired by Abyrx in April 2013.